Hepatocellular Carcinoma News and Research

RSS
Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

New method helps characterize immune cells in tumor tissues

New method helps characterize immune cells in tumor tissues

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Low levels of blood selenium may increase risk of liver cancer

Low levels of blood selenium may increase risk of liver cancer

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

FIB-4 index predicts HBV-related HCC

FIB-4 index predicts HBV-related HCC

Infant HBV vaccination prevents HCC in children, young adults

Infant HBV vaccination prevents HCC in children, young adults

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis

Novel enzyme immunoassay helps diagnose HCV infection in one simple step

Novel enzyme immunoassay helps diagnose HCV infection in one simple step

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

Scientists debate role of AAV in causing hepatocellular carcinoma

Scientists debate role of AAV in causing hepatocellular carcinoma

Researchers discover new potential treatment target for liver cancer

Researchers discover new potential treatment target for liver cancer

High levels of p62 protein in liver linked to cancer recurrence

High levels of p62 protein in liver linked to cancer recurrence

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

MUSC Hollings Cancer Center receives $8.9 million grant to explore signaling in sphingolipids

MUSC Hollings Cancer Center receives $8.9 million grant to explore signaling in sphingolipids

High-level quantum chemical computations help unravel underlying mechanism of hepatocellular toxicity

High-level quantum chemical computations help unravel underlying mechanism of hepatocellular toxicity

Antiviral therapies equal survival rate of HCV-related cirrhosis patients with general population

Antiviral therapies equal survival rate of HCV-related cirrhosis patients with general population

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.